Insider · CIK 0001834150
Decheng Capital Global Life Sciences Fund IV, L.P.
Files at AARD (Aardvark Therapeutics, Inc.). First filing Feb 19, 2025, latest Feb 19, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
AARD: Aardvark Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 57Moderate | Aardvark Therapeutics, Inc. | $20M 1,250,000 shares | +54% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 14, 2025 | AARD Aardvark Therapeutics, Inc. | CConversion Common Stockindirect: By Decheng Capital Global Life Sciences Fund IV, L.P. | +2,333,887 | - | - | 2,333,887 | Feb 19, 2025 |
| Feb 14, 2025 | AARD Aardvark Therapeutics, Inc. | CConversion Common Stockindirect: By Decheng Capital Global Healthcare Fund (Master), LP | +333,412 | - | - | 333,412 | Feb 19, 2025 |
| Feb 14, 2025 | AARD Aardvark Therapeutics, Inc. | POpen-market purchase Common Stockindirect: By Decheng Capital Global Life Sciences Fund IV, L.P. | +625,000 | $16.00 | $10M | 2,958,887 | Feb 19, 2025 |
| Feb 14, 2025 | AARD Aardvark Therapeutics, Inc. | POpen-market purchase Common Stockindirect: By Decheng Capital Global Healthcare Fund (Master), LP | +625,000 | $16.00 | $10M | 958,412 | Feb 19, 2025 |
| Feb 14, 2025 | AARD Aardvark Therapeutics, Inc. | CConversion Series C Convertible Preferred Stockderivativeindirect: By Decheng Capital Global Life Sciences Fund IV, L.P. | -19,777,363 | $0.00 | $0 | 0 | Feb 19, 2025 |
| Feb 14, 2025 | AARD Aardvark Therapeutics, Inc. | CConversion Series C Convertible Preferred Stockderivativeindirect: By Decheng Capital Global Healthcare Fund (Master), LP | -2,825,337 | $0.00 | $0 | 0 | Feb 19, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.